150 related articles for article (PubMed ID: 493456)
1. Annual meeting of the New Clinical Drug Evaluation Units (NCDEU) program, Psychopharmacology Research Branch, National Institute of Mental Health, 23-25 May 1978, Key Biscayne, Florida.
Psychopharmacol Bull; 1979 Jul; 15(3):22-44. PubMed ID: 493456
[No Abstract] [Full Text] [Related]
2. Annual NCDEU meeting 1988. Abridged proceedings. 28th annual meeting of the New Clinical Drug Evaluation Unit. May 31-June 3, 1988, Key Biscayne, Florida.
Psychopharmacol Bull; 1989; 25(1):1-153. PubMed ID: 2772108
[No Abstract] [Full Text] [Related]
3. Annual NCDEU meeting 1986. Abridged proceedings. New Clinical Drug Evaluation Unit. May 27-29, 1986, Key Biscayne, Florida.
Psychopharmacol Bull; 1987; 23(1):1-258. PubMed ID: 3602302
[No Abstract] [Full Text] [Related]
4. Annual NCDEU meeting 1987. Abridged proceedings. New Clinical Drug Evaluation Unit. May 26-28, 1987, Key Biscayne, Florida.
Psychopharmacol Bull; 1988; 24(1):1-209. PubMed ID: 3387512
[No Abstract] [Full Text] [Related]
5. Annual NCDEU meeting (1984). Abridged proceedings. New Clinical Drug Evaluation Unit, NIH. May 20-23, 1984, Key Biscayne, Florida.
Psychopharmacol Bull; 1985; 21(1):1-152. PubMed ID: 3983329
[No Abstract] [Full Text] [Related]
6. Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
Greenhill LL; Vitiello B; Abikoff H; Levine J; March JS; Riddle MA; Capasso L; Cooper TB; Davies M; Fisher P; Findling RL; Fried J; Labellarte MJ; McCracken JT; McMahon D; Robinson J; Skrobala A; Scahill L; Varipatis E; Walkup JT; Zito JM
J Am Acad Child Adolesc Psychiatry; 2003 Jun; 42(6):651-5. PubMed ID: 12921472
[TBL] [Abstract][Full Text] [Related]
7. Annual NCDEU meeting 1989. Abridged proceedings. 28th annual meeting of the New Clinical Drug Evaluation Unit. May 31-June 3, 1988, Key Biscayne, Florida.
Psychopharmacol Bull; 1989; 25(2):158-295. PubMed ID: 2602511
[No Abstract] [Full Text] [Related]
8. Annual NCDEU Meeting (1982)--abridged proceedings. New Clinical Drug Evaluation Unit, National Institute of Mental Health.
Psychopharmacol Bull; 1983; 19(1):23-140. PubMed ID: 6338549
[No Abstract] [Full Text] [Related]
9. Clinical development of anticancer agents--a National Cancer Institute perspective.
Marsoni S; Wittes R
Cancer Treat Rep; 1984 Jan; 68(1):77-85. PubMed ID: 6362870
[No Abstract] [Full Text] [Related]
10. NIH research evaluation: last meeting on clinical trials November 13, public comment allowed. National Institutes of Health.
AIDS Treat News; 1995 Nov; (no 234):5-6. PubMed ID: 11363042
[TBL] [Abstract][Full Text] [Related]
11. The uses of the intensive design in psychopharmacology.
Kellner R; Rifkin A; Rada RI
Psychopharmacol Bull; 1979 Jul; 15(3):35-7. PubMed ID: 493458
[No Abstract] [Full Text] [Related]
12. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
DeWys WD; Greenwald P
Semin Oncol; 1983 Sep; 10(3):360-4. PubMed ID: 6665563
[No Abstract] [Full Text] [Related]
13. A vision for the future: opportunities and challenges: notes from the director of the National Heart, Lung, and Blood Institute.
Nabel EG
Circulation; 2005 Jul; 112(1):145-6. PubMed ID: 15998699
[No Abstract] [Full Text] [Related]
14. Preparations for AIDS vaccine evaluations. AIDS International Training and Research Program.
Bridbord K
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S227-9. PubMed ID: 7865307
[No Abstract] [Full Text] [Related]
15. Clinical research programs in vision: The National Eye Institute perspective.
Goldberg IA
Am J Optom Physiol Opt; 1981 Apr; 58(4):270-6. PubMed ID: 7282850
[No Abstract] [Full Text] [Related]
16. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience.
Buchanan DR; White JD; O'Mara AM; Kelaghan JW; Smith WB; Minasian LM
J Clin Oncol; 2005 Sep; 23(27):6682-9. PubMed ID: 16170176
[TBL] [Abstract][Full Text] [Related]
17. Reorganization--psychopharmacology research branch, NIMH.
Psychopharmacol Bull; 1969 Jan; 5(1):1-2. PubMed ID: 5819584
[No Abstract] [Full Text] [Related]
18. Dosing strategies for antidepressant clinical trials: a commentary.
Robinson DS; Khan A
J Clin Psychopharmacol; 2004 Feb; 24(1):1-3. PubMed ID: 14709939
[No Abstract] [Full Text] [Related]
19. The application of the principles of clinical drug development to a pharmacological challenge test of the serotonergic system.
Pinder RM
J Psychopharmacol; 2004 Mar; 18(1):17; author reply 18-9. PubMed ID: 15107179
[No Abstract] [Full Text] [Related]
20. NIH role in clinical research. National Institutes of Health.
James JS
AIDS Treat News; 1995 Nov; (no 234):6-7. PubMed ID: 11363043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
